EGF and lung cancer: Interestingly, there was decreased phosphorylation of FAK and AKT in integrin β1–KO A549 cells prior to treatment with EGF, suggesting that integrin β1 signaling plays a role in the basal activation of these pathways in KRAS-mutated lung cancer cells.